
Novartis Receives Approval For First Malaria Medicine For Newborn Babies And Young Infants
(MENAFN- GlobeNewsWire - Nasdaq) Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by Swiss …